S.A. Mason’s Vertex Pharmaceuticals VRTX Stock Holding History

S.A. Mason’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$524K	Buy	+1,002	New	+$513K	0.15%	132

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Provident Investment Management Novi, Michigan $999M AUM 19.45% 1-Year Est. Return

S.A. Mason's VRTX Position: Q3 2026 in Review

S.A. Mason opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 1,002 shares worth $524K. The stake represents 0.15% of the portfolio and ranks #132 among its holdings.

478 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

S.A. Mason held 1,002 shares of Vertex Pharmaceuticals worth $524K as of Q3 2026.
Vertex Pharmaceuticals was a new S.A. Mason position in Q3 2026.
Vertex Pharmaceuticals made up 0.15% of S.A. Mason's portfolio in Q3 2026, its #132 holding.
478 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on S.A. Mason's 13F filing for Q3 2026, filed 13 Oct 2026.